Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
SAGE documentation
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (355)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1150)
Topics
Evidence to recommendation table (2)
GRADE table (2)
Meeting report (9)
Position paper (16)
SAGE background document (4)
Regions
Global (1)
Diseases
COVID-19 (34)
Cholera (5)
Dengue (13)
Diphtheria (4)
Ebola (6)
Haemophilus influenzae type B (4)
Hepatitis A (11)
Hepatitis B (4)
Hepatitis E (2)
Herpes zoster (2)
Human papillomavirus (HPV) (18)
Influenza (17)
Japanese encephalitis (10)
Malaria (13)
Measles (14)
Meningococcal disease (7)
Mpox (7)
Mumps (2)
Pertussis (4)
Pneumococcal disease (12)
Poliomyelitis (20)
Rabies (5)
Rotavirus (1)
RSV (Respiratory syncytial virus) (4)
Rubella (8)
Smallpox (1)
Tetanus (2)
Tick-borne encephalitis (1)
Tuberculosis (9)
Typhoid (8)
Varicella (3)
Yellow fever (3)
Show more
Methodological quality (AMSTAR 2)
Not applicable (1)
Publication date
2026 (1)
2024 (2)
2023 (4)
2022 (18)
2021 (6)
2020 (3)
Available to download in languages
en (32)
34 results found
2022
∙
SAGE
Annexes to the interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
2022
∙
SAGE
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
2022
∙
SAGE
Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
2022
∙
SAGE
WHO interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2 - 18 August 2022
2022
∙
SAGE
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
2022
∙
SAGE
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm
2022
∙
SAGE
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
2022
∙
SAGE
Good practice statement on the use of second booster doses for COVID-19 vaccines
2022
∙
SAGE
Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
2022
∙
SAGE
Background document on the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register